Skip to main content

Coronavirus Infections

Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial.

Oppegaard O. The Lancet Infectious Diseases 2026;:https://doi.org/10.1016/S1473-3099(26)00244-6.

Published on 23/7/2026
Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial.

STIMULATE-ICP consortium. The Lancet Infectious Diseases 2026;:https://doi.org/10.1016/S1473-3099(26)00242-2.

Published on 23/7/2026
Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical Trial.

Kandel C. JAMA Internal Medicine 2026;:doi: 10.1001/jamainternmed.2026.2644.

Published on 10/8/2026
National flu and COVID-19 surveillance reports: 2026 to 2027 season.

UK Health Security Agency (UKHSA); 2026.

Published on 20/7/2026
COVID-19 vaccination in autumn 2027: JCVI advice.

Department of Health and Social Care (DHSC); 2026.

Published on 20/7/2026
'I Want Everyone to Have It, and Everyone to Be on It': A Feasibility Study of the Transforming Long Covid Intervention.

Health Expectations; 2026.

Published on 13/7/2026
Psychological and Cognitive Sequelae of COVID-19: Systematic Review and Meta-Analysis.

Boufleuer E. Journal of Psychiatric and Mental Health Nursing 2026;33(4):653-666.

Published on 30/7/2026
Cognitive Rehabilitation and Functional Outcomes in Long COVID-Related Cognitive Impairment: A Randomized Clinical Trial.

Vanova M. JAMA Network Open 2026;9(7):e2620687.

Published on 31/7/2026
Mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals (the MOSAIC study): an open-label, single-centre, randomised controlled trial.

Akiyama MJ. The Lancet Public Health 2026;:https://doi.org/10.1016/S2468-2667(26)00093-9.

Published on 13/7/2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELY.

Russell MD. The Lancet Rheumatology 2026;:https://doi.org/10.1016/S2665-9913(26)00142-6.

Published on 13/7/2026

1
2
3
4
...